Search results
Results From The WOW.Com Content Network
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States.It is tasked with allocating about $3.6 billion in FY 2020 [1] in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease ...
The mission of the NIH OTT is to improve public health through the management of inventions made by NIH and FDA scientists and the development of intellectual property policies for NIH's intramural and extramural research programs. In doing so, OTT serves a leading role in public sector biomedical technology transfer policy and practice.
She serves as a senior advisor to the NHLBI Director and provides strategic direction to scientific initiatives and programs related to the NHLBI mission. In her various roles at NIH, Paltoo has partnered across the NIH, Department of Health and Human Services , and Federal agencies on initiatives and activities relevant to open science, data ...
The Strong Heart Study is an ongoing cohort study of cardiovascular disease (CVD) and its risk factors among American Indian men and women. The original cohort began in 1984 with 4,549 participants ages 35–74 from 13 tribal nations and communities in Arizona, Oklahoma, North Dakota, and South Dakota.
The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". [3] NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH.
==Summary== {{Information |Description=Logo of the United States w: National Heart, Lung, and Blood Institute, part of the w:National Institutes of Health. The logo depicts a red heart, surrounded by two white lungs, encased in a red blood cell
Julie Ann Panepinto is an American pediatric hematologist-oncologist and physician-scientist.She specializes in health outcomes research and sickle cell disease.Panepinto became the acting director of the division of blood diseases and resources at the National Heart, Lung, and Blood Institute in 2022.
Roger received a medical degree in 1986 from Sorbonne University and a Master in Public Health in Epidemiology at the University of Minnesota in 1996. [1] [2] After training in cardiology at the Mayo Clinic, she joined the faculty in 1992 and became professor in medicine in 2002 and epidemiology in 2006. [1]